Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin.

Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin. Diab Vasc Dis Res. 2011 Jul; 8(3):195-201.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.